✦ LIBER ✦

PIN42 Cost-Effectiveness-Analysis of the Combination- Therapy Telaprevir, Peg-IFNα2a and Ribavirin in Patients With Chronic Hepatitis-C in Austria

✍ Scribed by M. Said; A. Dragosits; E. Walter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A health economic model to assess the co

✍ S. Gerkens; M. Nechelput; L. Annemans; B. Peraux; M. Mouchart; C. Beguin; Y. Hor 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

PGI25 Cost-Utility Analysis of Telaprevi

✍ M. Lukac; J. Bielik; J. Holoman; D. Tomek; A. Suvadova; T. Foltanova; V. Foltan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Combination Treatment of IFNα2band Ribav

✍ Andreas Erhardt; Ulla Behlen-Wilm; Ortwin Adams; Andreas Donner; Tobias Heintges 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 136 KB

PIN81 Cost-Effectiveness Analysis of Peg

✍ W. Chen; L. Wei 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PGI8 COST-EFFECTIVENESS OF PEG-IFN ALPHA

✍ G Salinas Escudero; J Idrovo; R Rivas; J Ramirez Rodriguez; IA Rico Alba; L Zapa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Studies of Therapy with Thymosin α1 in C

✍ ROBERTO CAMERINI; ALESSIA CIANCIO; ALFONSO DE ROSA; MARIO RIZZETTO 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB